MONDELEZ INTERNATIONAL INC-A (MDLZ) Fundamental Analysis & Valuation
NASDAQ:MDLZ • US6092071058
Current stock price
56.21 USD
-0.28 (-0.5%)
At close:
56.56 USD
+0.35 (+0.62%)
After Hours:
This MDLZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MDLZ Profitability Analysis
1.1 Basic Checks
- In the past year MDLZ was profitable.
- MDLZ had a positive operating cash flow in the past year.
- In the past 5 years MDLZ has always been profitable.
- Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
- MDLZ has a better Return On Assets (3.43%) than 66.67% of its industry peers.
- The Return On Equity of MDLZ (9.49%) is better than 72.41% of its industry peers.
- MDLZ has a better Return On Invested Capital (5.26%) than 60.92% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is in line with the industry average of 7.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.43% | ||
| ROE | 9.49% | ||
| ROIC | 5.26% |
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
1.3 Margins
- With an excellent Profit Margin value of 6.36%, MDLZ belongs to the best of the industry, outperforming 81.61% of the companies in the same industry.
- In the last couple of years the Profit Margin of MDLZ has declined.
- The Operating Margin of MDLZ (9.48%) is better than 75.86% of its industry peers.
- MDLZ's Operating Margin has declined in the last couple of years.
- MDLZ has a better Gross Margin (28.38%) than 67.82% of its industry peers.
- In the last couple of years the Gross Margin of MDLZ has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.48% | ||
| PM (TTM) | 6.36% | ||
| GM | 28.38% |
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
2. MDLZ Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
- Compared to 1 year ago, MDLZ has less shares outstanding
- The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
- MDLZ has a worse debt/assets ratio than last year.
2.2 Solvency
- MDLZ has an Altman-Z score of 2.22. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
- MDLZ has a Altman-Z score (2.22) which is in line with its industry peers.
- MDLZ has a debt to FCF ratio of 6.55. This is a slightly negative value and a sign of low solvency as MDLZ would need 6.55 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 6.55, MDLZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
- MDLZ has a Debt/Equity ratio of 0.77. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
- MDLZ has a Debt to Equity ratio (0.77) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 6.55 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.69
WACC7.58%
2.3 Liquidity
- A Current Ratio of 0.59 indicates that MDLZ may have some problems paying its short term obligations.
- The Current ratio of MDLZ (0.59) is worse than 85.06% of its industry peers.
- MDLZ has a Quick Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDLZ's Quick ratio of 0.39 is on the low side compared to the rest of the industry. MDLZ is outperformed by 81.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.39 |
3. MDLZ Growth Analysis
3.1 Past
- The earnings per share for MDLZ have decreased strongly by -15.36% in the last year.
- The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
- MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
- MDLZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.71% yearly.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
3.2 Future
- MDLZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.76% yearly.
- MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue Next Year3.59%
Revenue Next 2Y3.39%
Revenue Next 3Y3.33%
Revenue Next 5Y3.25%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. MDLZ Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 19.25, which indicates a rather expensive current valuation of MDLZ.
- Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
- The average S&P500 Price/Earnings ratio is at 25.23. MDLZ is valued slightly cheaper when compared to this.
- A Price/Forward Earnings ratio of 18.14 indicates a rather expensive valuation of MDLZ.
- The rest of the industry has a similar Price/Forward Earnings ratio as MDLZ.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, MDLZ is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.25 | ||
| Fwd PE | 18.14 |
4.2 Price Multiples
- MDLZ's Enterprise Value to EBITDA is on the same level as the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 60.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.27 | ||
| EV/EBITDA | 17.72 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.15
PEG (5Y)8.78
EPS Next 2Y8.63%
EPS Next 3Y8.1%
5. MDLZ Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.68%, MDLZ has a reasonable but not impressive dividend return.
- MDLZ's Dividend Yield is a higher than the industry average which is at 2.45.
- MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.68% |
5.2 History
- On average, the dividend of MDLZ grows each year by 10.23%, which is quite nice.
- MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
- MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.23%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- 101.47% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
- The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
MDLZ Fundamentals: All Metrics, Ratios and Statistics
56.21
-0.28 (-0.5%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)04-27 2026-04-27/amc
Inst Owners88.72%
Inst Owner Change-0.62%
Ins Owners0.18%
Ins Owner Change5.05%
Market Cap72.05B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts77.65
Price Target67.99 (20.96%)
Short Float %2.62%
Short Ratio3.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.68% |
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31 2026-03-31 (0.5)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-0.22%
PT rev (3m)-2.97%
EPS NQ rev (1m)-2.44%
EPS NQ rev (3m)-24.25%
EPS NY rev (1m)-3.08%
EPS NY rev (3m)-3.84%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.25 | ||
| Fwd PE | 18.14 | ||
| P/S | 1.87 | ||
| P/FCF | 22.27 | ||
| P/OCF | 15.96 | ||
| P/B | 2.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.72 |
EPS(TTM)2.92
EY5.19%
EPS(NY)3.1
Fwd EY5.51%
FCF(TTM)2.52
FCFY4.49%
OCF(TTM)3.52
OCFY6.26%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)3.15
PEG (5Y)8.78
Graham Number36.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.43% | ||
| ROE | 9.49% | ||
| ROCE | 7.36% | ||
| ROIC | 5.26% | ||
| ROICexc | 5.48% | ||
| ROICexgc | 44.22% | ||
| OM | 9.48% | ||
| PM (TTM) | 6.36% | ||
| GM | 28.38% | ||
| FCFM | 8.39% |
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.26%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y1.32%
ROICexc growth 5Y-3.02%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 6.55 | ||
| Debt/EBITDA | 3.97 | ||
| Cap/Depr | 94.18% | ||
| Cap/Sales | 3.32% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 90.06% | ||
| Profit Quality | 131.99% | ||
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.22 |
F-Score5
WACC7.58%
ROIC/WACC0.69
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.59%
Revenue Next 2Y3.39%
Revenue Next 3Y3.33%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.43%
EBIT growth 3Y-1.61%
EBIT growth 5Y-2.57%
EBIT Next Year34.33%
EBIT Next 3Y15.04%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%
MONDELEZ INTERNATIONAL INC-A / MDLZ Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for MDLZ stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.25 and the Price/Book (PB) ratio is 2.79.
Can you provide the dividend sustainability for MDLZ stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.